PMV PHARMACEUTICALS INC shareholders Q3 2023

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.

PMV PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PDT Partners, LLC 41,988$257,8060.03%
Alkeon Capital Management 2,347,414$14,413,1220.03%
HARBOURVEST PARTNERS LLC 11,533$70,8130.02%
FISHMAN JAY A LTD/MI 30,000$184,2000.02%
ArrowMark Colorado Holdings LLC 270,426$1,660,4160.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,000$583,3000.01%
FEDERATED HERMES, INC. 783,539$4,810,9290.01%
Trexquant Investment LP 68,202$418,7600.01%
Baker Brothers Advisors 322,024$1,977,2270.01%
Vontobel Holding Ltd. 303,824$1,865,4790.01%
ALGERT GLOBAL LLC 27,790$1710.01%
GSA CAPITAL PARTNERS LLP 13,045$800.01%
Assenagon Asset Management S.A. 258,538$1,587,4230.01%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 74,525$457,5840.01%
Connor, Clark & Lunn Investment Management Ltd. 169,699$1,041,9520.01%
MARTINGALE ASSET MANAGEMENT L P 29,296$179,8780.00%
PRINCIPAL FINANCIAL GROUP INC 919,142$5,643,5280.00%
JPMORGAN CHASE & CO 4,033,721$24,767,0460.00%
Schonfeld Strategic Advisors LLC 71,295$437,7510.00%
Citadel Advisors 1,922,357$11,803,2720.00%
External links

This page lists PMV PHARMACEUTICALS INC's shareholders in Q3 2023. To view PMV PHARMACEUTICALS INC's shareholder history, click here.